StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Expert Call Increases Confidence In The Acceleration Of Pfizer's (PFE) ATTRCM Diagnosis Rate - BMO
September 10, 2018 8:25 AM
BMO Capital analyst, Alex Arfaei, reiterated his Outperform rating on shares of Pfizer (NYSE: PFE) after speaking with a leading ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments